HAV VP3, Hepatitis A Virus Antigen, Recombinant

Full Name

Abbreviated Name-1

HAV-VP3; Hepatitis A Virus VP3

Documents
Figures
Reference
Haro I, et al. Liposome entrapment and immunogenic studies of a synthetic lipophilic multiple antigenic peptide bearing VP1 and VP3 domains of the hepatitis A virus: a robust method for vaccine design. FEBS Lett. Apr 2003; 540(1-3): 133-140. Kanda T, et al. Hepatitis A virus VP3 may activate serum response element associated transcription. Scand. J. Gastroenterol. Mar 2003; 38(3): 307-313. Sospedra P, et al. Interaction study of peptide from VP3 capsid protein of hepatitis A virus through monolayers and fluorescence spectroscopy. Luminescence. Mar-Apr 2001; 16(2): 103-107.

Description

The protein Hepatitis A Virus (HAV) VP3 contains the HAV VP3 immunodominant regions, amino acids: 304-415.

Source

E. coli

M.W.

29,000 Da

Purity

Protein is >90% pure as determined by 10% PAGE (coomassie staining).

Storage

Protein is shipped at ambient temperature. Upon arrival, store at -20°C.

Concentration

1 mg/ml in 10 mM CBB, pH 9.6, 0.1% SDS, 50% glycerol

Stability

Five years frozen, one month in solution at room temperature

Specificity

Immunoreactive with sera of HAV-infected individuals

Applications

Antigen in ELISA and Western blots, excellent antigen for detection of HAV with minimal specificity problems.

Note

;

Cat. No.	Name	Size	Price
Z00022	HAV P2C, Hepatitis A Virus Antigen, Recombinant	1 mg	$1000
Z00023	HAV P2C-P3A, Hepatitis A Virus Antigen, Recombinant	1 mg	$1000
Z00024	HAV P3C, Hepatitis A Virus Antigen, Recombinant	1 mg	$1000
Z00025	HAV VP1, Hepatitis A Virus Antigen, Recombinant	1 mg	$1000
Z00026	HAV VP1-P2A, Hepatitis A Virus Antigen, Recombinant	1 mg	$420
Z00028	HAV VP4-VP2, Hepatitis A Virus Antigen, Recombinant	1 mg	$1000


1	Custom Recombinant Protein Services: Guaranteed E. coli Expression Package-3 mg purified soluble protein from $2,200 .
2	Bacterial Expression System: GenScript has developed BacPower^TM technologies to tackle hard-to-express and hard-to-dissolve proteins.
3	Yeast Expression System: GenScript's proprietary YeastHIGH^TM technology combines the advantages of the bacterial and eukaryotic expression systems.
4	Baculovirus/Insect Cell Expression System: GenScript developed BacuVance^TM platform for the secretion of recombinant proteins from baculovirus-infected insect cells.
5	Mammalian Cell Expression System: The proprietary 293 and CHO suspension system platform promotes fast production and delivery of recombinant proteins and monoclonal antibodies up to grams level.